Skip to main navigation Skip to search Skip to main content

Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation

  • Tae Jin Lee
  • , Ju Hwan Kim
  • , Se Jeong Kwon
  • , Sun Hee Park
  • , Jinyoung Kim
  • , Hyo Jin Kang
  • , Sang J. Chung
  • Sungkyunkwan University
  • AbTis Company Ltd.
  • Gyeonggido Business Science Accelerator

Research output: Contribution to journal › Article › peer-review

Abstract

Antibody-drug conjugates (ADCs) in current clinical usage have been constructed via the nonspecific conjugation of drugs to antibodies, rendering the manufacturing processes difficult. In this study, a high-affinity IgG Fc-binding peptide equipped with a photoreactive amino acid was developed and successfully conjugated to Glu-382 of trastuzumab in a site-specific manner. The resulting conjugate was employed to generate a DAR 2 ADC product using click chemistry.

Original languageEnglish
Pages (from-to)8419-8423
Number of pages5
JournalOrganic Letters
Volume22
Issue number21
DOIs
StatePublished - 6 Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Fingerprint

Dive into the research topics of 'Photoconjugation of an Fc-Specific Peptide Enables Efficient DAR 2 Antibody-Drug Conjugate Formation'. Together they form a unique fingerprint.

Cite this